GOLDEN, Colo., Dec. 18, 2015 /PRNewswire/ -- BiO2 Medical is pleased to announce that The Angel® Catheter Clinical Trial, the pivotal investigation of the Angel® Catheter, has successfully ...
BiO2 Medical Executes Full Commercialization in the United Kingdom Partnering with United Drug Medical (UDM) as an Exclusive Distributor for the Angel® Catheter
BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, has signed a distribution agreement with Pyramed, a division of United Drug Medical (UDM). This milestone accomplishment grants Pyramed exclusive rights to distribute the Angel® Catheter throughout ...
GOLDEN, Colo., Jan. 6, 2016 /PRNewswire/ -- Following the successful completion of The Angel® Catheter Clinical Trial, BiO2Medical, Inc. reports that it has raised approximately $9 ...
BiO2 Medical Executes Q4 2013 Commercialization Strategy for the Angel® Catheter, Signing Distribution Partnership Agreements in Key European and Middle Eastern Geographies
BiO2 Medical has achieved Q4 2013 global expansion goals for the Angel® Catheter, a novel Central Venous Catheter (CVC) with a permanently attached retrievable Inferior Vena Cava (IVC) filter to provide Pulmonary Embolism (PE) protection for critically ill patients. The Angel® Catheter is the first ...